SCHEMBL312382

SCHEMBL312382

CCOC(=O)Nc1cc(O)ccc1-c1cc(=O)c2c(O)cc(O)cc2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
GAA P10253 2/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA7 P43166 2/20 0.36
CA9 Q16790 2/20 0.36
CA14 Q9ULX7 2/20 0.36
ALOX5 P09917 2/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
KCNQ2 O43526 1/20 0.35
MAOB P27338 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311753 0.89 ALDH1A1 (0.43) CYP1A2CYP2C9CYP2C19SMN1; SMN2MEN1
SCHEMBL311043 0.87 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19SMN1; SMN2MEN1
SCHEMBL312241 0.86 ALDH1A1 (0.43) CYP1A2CYP2C9CYP2C19SMN1; SMN2MEN1
SCHEMBL311592 0.85 NPC1 (0.38) CYP1A2CYP2C9CYP2C19SMN1; SMN2MEN1
SCHEMBL311889 0.84 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19SMN1; SMN2MEN1
SCHEMBL312303 0.84 TUBB4A (0.40) CYP1A2CYP2C9CYP2C19SMN1; SMN2MEN1
SCHEMBL311883 0.84 GAA (0.46) CYP1A2CYP2C9CYP2C19SMN1; SMN2MEN1
SCHEMBL312297 0.83 NLRP3 (0.42) CYP1A2CYP2C9CYP2C19SMN1; SMN2MEN1
SCHEMBL312363 0.83 CYP1A2 (0.37) CYP1A2CYP2C9CYP2C19SMN1; SMN2MEN1
SCHEMBL10215441 0.82 KDM4E (0.45) SMN1; SMN2MEN1KMT2AGAAALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed